New implant could replace eye drops for keratoconus patients after surgery
NCT ID NCT06235567
First seen Mar 30, 2026 · Last updated May 08, 2026 · Updated 4 times
Summary
This study tests if a tiny steroid-releasing implant called Dextenza works as well as standard steroid eye drops for reducing inflammation after corneal crosslinking surgery in people with keratoconus. About 20 participants aged 13 and older will receive either the implant or eye drops. The goal is to offer an easier option for those who struggle with using eye drops regularly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mission Bay Hospital
San Francisco, California, 94158, United States
-
UCSF Pediatric Ophthalmology
San Francisco, California, 94158, United States
-
Wayne and Gladys Center for Vision
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.